The Wall Street Journal: Experimental peanut-allergy drug shows encouraging results in protecting kids

An experimental drug derived from peanuts protected some children and adolescents with life-threatening peanut allergies, according to a study, allowing the subjects to eat small amounts of peanuts without suffering a serious reaction.

The drug, from a small California company, Aimmune Therapeutics, didn’t work for everyone, has some side effects and hasn’t been approved by regulators for sale. Yet the findings from the late-stage trial promise a potential new solution for peanut allergies, a growing concern.

Peanut allergies have emerged as a life-threatening peril for many parents, forcing them to pore over ingredients for any signs of peanuts and to equip their children — and their children’s schools — with devices to help with sudden and unexpected allergic reactions.

>>> Original Source <<<